Hjem › Prostatakreft › District of Columbia
Kliniske studier for Prostatakreft i District of Columbia
18 studier for Prostatakreft søker deltakere på steder i District of Columbia.
Byer i District of Columbia
Offisiell studietekst (engelsk)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 2. okt. 2026 · NCT06931340Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- MedStar Georgetown University Hospital, Washington D.C.
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT03866382A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- MedStar Washington Hospital Center ( Site 0103), Washington D.C.
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06136650Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
RekruttererFase 2
Alder 18 og eldre · Menn · Oppdatert 17. sep. 2026 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- The GW Medical Faculty Associates ( Site 0057), Washington D.C.
- Washington DC Veterans Affairs Medical Center ( Site 0056), Washington D.C.
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 17. sep. 2026 · NCT06925737Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- George Washington University Medical Center, Washington D.C.
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 10. sep. 2026 · NCT05946213MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
RekruttererFase 2
Alder 18 og eldre · Menn · Oppdatert 20. aug. 2026 · NCT07644598Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Sibley Memorial Hospital, Washington D.C.
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 19. aug. 2026 · NCT04423211FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT05919264Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Sibley Memorial Hospital, Washington D.C.
- George Washington University Medical Center, Washington D.C.
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 14. jul. 2026 · NCT06592924Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- VA Medical Center, Washington D.C.
RekruttererFase 4
Alder 18 til 100 · Menn · Oppdatert 4. jun. 2026 · NCT05803941Cancer Experience Registry (CER) for Cancer Patients and Caregivers
- Cancer Support Community Research & Training Institute, Washington D.C.
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 23. apr. 2026 · NCT02333604Clinical Trial of Approaches to Prostate Cancer Surgery
- Georgetown University, Washington D.C.
Rekrutterer
Alder 40 til 80 · Menn · Oppdatert 22. apr. 2026 · NCT05155501Castrate Resistant Prostate Cancer Enhertu Therapy
- Washington DC VAMC, Washington D.C.
RekruttererFase 2
Alder 18 og eldre · Menn · Oppdatert 13. apr. 2026 · NCT06610825Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
RekruttererFase 2/3
Alder 18 og eldre · Menn · Oppdatert 8. apr. 2026 · NCT04787744Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
- Howard University Hospital, Washington D.C.
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 40 til 69 · Menn · Oppdatert 10. nov. 2025 · NCT06398639Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- George Washington University Medical Center, Washington D.C.
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 11. sep. 2025 · NCT03678025Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.